Vasoactive intestinal polypeptide gene expression is characteristically higher in opossum gastrointestinal sphincters.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  J. Szurszewski,et al.  Role of nitric oxide in gastrointestinal and hepatic function and disease. , 1992, Gastroenterology.

[3]  S. Schiffmann,et al.  Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis. , 1992, The New England journal of medicine.

[4]  S. Said.  Nitric Oxide and Vasoactive Intestinal Peptide: Cotransmitters of Smooth Muscle Relaxation , 1992 .

[5]  S. Rattan,et al.  Nitric oxide pathway in rectoanal inhibitory reflex of opossum internal anal sphincter. , 1992, Gastroenterology.

[6]  G. Makhlouf,et al.  Stimulation of nitric oxide from muscle cells by VIP: prejunctional enhancement of VIP release. , 1992, The American journal of physiology.

[7]  R. Yalow,et al.  Isolation and amino acid sequences of opossum vasoactive intestinal polypeptide and cholecystokinin octapeptide. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Ward,et al.  Nitric oxide as a mediator of nonadrenergic noncholinergic neurotransmission. , 1992, The American journal of physiology.

[9]  A. Tøttrup,et al.  Involvement of the L-arginine-nitric oxide pathway in internal anal sphincter relaxation. , 1992, Gastroenterology.

[10]  M. Rand,et al.  Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus. , 1990, European journal of pharmacology.

[11]  G. Burnstock,et al.  Vasoactive intestinal polypeptide levels in sigmoid colon in idiopathic constipation and diverticular disease. , 1990, Gastroenterology.

[12]  J. Szurszewski,et al.  Altered inhibitory innervation of circular smooth muscle in Crohn's colitis. Association with decreased vasoactive intestinal polypeptide levels. , 1990, Gastroenterology.

[13]  J. Dent,et al.  Inhibitory function of VIP-PHI and galanin in canine pylorus. , 1989, The American journal of physiology.

[14]  J. Waschek,et al.  Lineage-specific regulation of the vasoactive intestinal peptide gene in neuroblastoma cells is conferred by 5.2 kilobases of 5'-flanking sequence. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Burnstock,et al.  Reversal of nerve damage in streptozotocin-diabetic rats by acute application of insulin in vitro. , 1988, Clinical science.

[16]  F. Sundler,et al.  Vasoactive Intestinal Peptide in the Peripheral Nervous System a , 1988, Annals of the New York Academy of Sciences.

[17]  J. Wiley,et al.  Vasoactive intestinal polypeptide mediates cholecystokinin-induced relaxation of the sphincter of Oddi. , 1988, The Journal of clinical investigation.

[18]  J. Behar,et al.  Dysfunction of the Gastrointestinal Tract. Vasoactive Intestinal Peptide in Peristalsis and Sphincter Function , 1988, Annals of the New York Academy of Sciences.

[19]  A. Cancellieri,et al.  Intramural distribution of regulatory peptides in the sigmoid-recto-anal region of the human gut. , 1988, Gut.

[20]  S. Rattan,et al.  Role of vasoactive intestinal polypeptide in the internal anal sphincter relaxation of the opossum. , 1988, The Journal of clinical investigation.

[21]  S. Rattan,et al.  Influence of sacral nerves on the internal anal sphincter of the opossum. , 1987, The American journal of physiology.

[22]  S J H Brookes,et al.  The Enteric Nervous System , 2016, Advances in Experimental Medicine and Biology.

[23]  T. Williams,et al.  Distribution of vasoactive intestinal polypeptide-immunoreactive structures in the opossum esophagus. , 1987, Gastroenterology.

[24]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[25]  M. Costa,et al.  Abnormalities of peptide-containing nerve fibers in infantile hypertrophic pyloric stenosis. , 1987, Gastroenterology.

[26]  S. Rattan.  The non-adrenergic non-cholinergic innervation of the esophagus and the lower esophageal sphincter. , 1986, Archives internationales de pharmacodynamie et de therapie.

[27]  H. Okamoto,et al.  Synergistic stimulation of VIPPHM-27 gene expression by cyclic AMP and phorbol esters in human neuroblastoma cells , 1985 .

[28]  H. Okamoto,et al.  Nucleotide sequence divergence and functional constraint in VIP precursor mRNA evolution between human and rat , 1985, FEBS letters.

[29]  J. Szurszewski,et al.  Vasoactive intestinal polypeptide: a putative transmitter in the canine gastric muscularis mucosa. , 1983, The Journal of physiology.

[30]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[31]  F. Sundler,et al.  Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. , 1983, Gastroenterology.

[32]  S. Rattan,et al.  Vasoactive intestinal peptide causes peristaltic contractions in the esophageal body. , 1982, Life sciences.

[33]  G. Makhlouf,et al.  Receptors on smooth muscle cells: characterization by contraction and specific antagonists. , 1982, The American journal of physiology.

[34]  M. Reinecke,et al.  VIP immunoreactivity in enteric nerves and endocrine cells of the vertebrate gut , 1981, Peptides.

[35]  S. Rattan,et al.  VIP as a possible neurotransmitter of non-cholinergic non-adrenergic inhibitory neurones , 1980, Nature.

[36]  J. Fahrenkrug,et al.  Vasoactive intestinal polypeptide , 1980, Trends in Neurosciences.

[37]  M. Costa,et al.  Projections of intestinal neurons showing immunoreactivity for vasoactive intestinal polypeptide are consistent with these neurons being the enteric inhibitory neurons , 1979, Neuroscience Letters.

[38]  F. Sundler,et al.  A rich VIP nerve supply is characteristic of sphincters , 1979, Nature.

[39]  F. Sundler,et al.  Peptidergic (VIP) innervation of the esophagus. , 1978, Gastroenterology.

[40]  S. Said,et al.  Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors. , 1975, The New England journal of medicine.

[41]  P. Leder,et al.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Facer,et al.  Vasoactive intestinal polypeptide gene expression in the developing human gastrointestinal tract. , 1992, Gastroenterology.

[43]  S. Rattan,et al.  Role of nitric oxide as a mediator of internal anal sphincter relaxation. , 1992, The American journal of physiology.

[44]  J. Grider,et al.  Regulation of the peristaltic reflex by peptides of the myenteric plexus. , 1990, Archives internationales de pharmacodynamie et de therapie.

[45]  J. Fahrenkrug.  VIP and autonomic neurotransmission. , 1989, Pharmacology & therapeutics.

[46]  V. Mutt,et al.  Vasoactive intestinal peptide and related peptides. , 1988, Annals of the New York Academy of Sciences.

[47]  T. Hökfelt,et al.  Structure and expression of the gene encoding the vasoactive intestinal peptide precursor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[48]  P. Thomas,et al.  Hybridization of denatured RNA transferred or dotted nitrocellulose paper. , 1983, Methods in enzymology.

[49]  A. Bandyopadhyay.  Purification and properties of nuclear and cytoplasmic DNA polymerases from JLS-V9 cells. , 1975, Archives of biochemistry and biophysics.